APCCC Panel 2022 & Scientific Committee

Panel Members

Antonarakis Emmanuel United States Medical Oncology
Aparicio Ana United States Medical Oncology
Armstrong Andrew United States Medical Oncology
Attard Gerhardt United Kingdom Medical Oncology
Beer Tomasz M. United States Medical Oncology
Beltran Himisha United States Medical Oncology
Bjartell Anders Sweden Urology
Blanchard Pierre France Urology
Bossi Alberto France Radiation Oncology
Briganti Alberto Italy Urology
Bristow Rob United Kingdom Radiation Oncology
Bulbul Muhammad Lebanon Urology
Caffo Orazio Italy Medical Oncology
Castellano Daniel Spain Medical Oncology
Castro Elena Spain Medical Oncology
Cheng Heather United States Medical Oncology
Chi Kim N. Canada Medical Oncology
Chowdhury Simon United Kingdom Medical Oncology
Clarke Caroline S. United Kingdom Health Economics
Clarke Noel United Kingdom Urology
Daugaard Gedske Denmark Medical Oncology
Davis Ian Australia Medical Oncology
de Bono Johann United Kingdom Medical Oncology
De Santis Maria Germany Medical Oncology
Duran Ignacio Spain Medical Oncology
Eeles Ros United Kingdom Clinical Oncology and Genetics
Efstathiou Eleni United States Medical Oncology
Efstathiou Jason United States Radiation Oncology
Ekeke Onyeanunam Ngozi Nigeria Urology
Evans Christopher United States Urology
Fanti Stefano Italy Nuclear Medicine
Feng Felix Y. United States Radiation Oncology
Fisher Jane Australia Movember representative
Fizazi Karim France Medical Oncology
Fonteyne Valerie Belgium Radiation Oncology
Fossati Nicola Switzerland Urology
Frydenberg Mark Australia Urology
George Dan United States Medical Oncology
Gillessen Silke Switzerland Medical Oncology
Gleave Martin Canada Urology
Gravis Gwenaelle France Medical Oncology
Halabi Susan United States Clinical trials and Statistics
Heinrich Daniel Norway Clinical Oncology
Herrmann Ken Germany Nuclear Medicine
Higano Celestia United States Medical Oncology
Hofman Michael Australia Nuclear Medicine
Horvath Lisa Australia Medical Oncology
Hussain Maha United States Medical Oncology
James Nicholas D. United Kingdom Clinical Oncology
Jereczek-Fossa Barbara Alicja Italy Radiation Oncology
Jones Rob United Kingdom Medical Oncology
Kanesvaran Ravindran Singapore Medical Oncology
Kellokumpu-Lethinen Pirkko-Liisa Finnland Clinical Oncology
Khauli Raja B. Lebanon Urology
Klotz Laurence Canada Urology
Kramer Gero Austria Urology
Leibowitz Raya Israel Medical Oncology
Logothetis Christopher J. United States Medical Oncology
Mahal Brandon A. United States Radiation Oncology
Maluf Fernando Brasil Medical Oncology
Mateo Joaquin Spain Medical Oncology
Matheson David United Kingdom Patient advocate
Mehra Niven Netherlands Medical Oncology
Merseburger Axel Germany Urology
Morgans Alicia K. United States Medical Oncology
Morris Michael United States Medical Oncology
Mottet Nicolas France Urology
Mrabti Hind Morocco Medical Oncology
Mukherji Deborah Emirates Medical Oncology
Murphy Declan G. Australia Urology
Murthy Vedang India Radiation Oncology
Nguyen Paul United States Radiation Oncology
O’Sullivan Joe M. United Kingdom Clinical Oncology
Oh William K. United States Medical Oncology
Omlin Aurelius Switzerland Medical Oncology
Ost Piet Belgium Radiation Oncology
Padhani Anwar R. United Kingdom Radiology
Pezaro Carmel United Kingdom Medical Oncology
Poon Darren M.C. Hong Kong Clinical Oncology
Pritchard Colin C. United States Pathology
Rabah Danny M. Saudi Arabia Urology
Rathkopf Dana United States Medical Oncology
Reiter Robert E. United States Urology
Rubin Mark A. Switzerland Pathology
Ryan Charles J. United States Medical Oncology
Saad Fred Canada Urology
Sade Juan Pablo Argentina Medical Oncology
Sartor Oliver A. United States Medical Oncology
Scher Howard I. United States Medical Oncology
Sharifi Nima United States Medical Oncology
Shore Neal United States Urology
Skoneczna Iwona Poland Clinical Oncology
Small Eric United States Medical Oncology
Smith Matthew United States Medical Oncology
Soule Howard United States Prostate Cancer Foundation
Spratt Daniel E. United States Radiation Oncology
Srinivas Sandy United States Medical Oncology
Sternberg Cora United States Medical Oncology
Steuber Thomas Germany Urology
Suzuki Hiroyoshi Japan Urology
Sweeney Christopher United States Medical Oncology
Sydes Matthew R. United Kingdom Clinical trials and Statistics
Taplin Mary-Ellen United States Medical Oncology
Tilki Derya Germany Urology
Tombal Bertrand Belgium Urology
Türkeri Levent Turkey Urology
Uemura Hiroji Japan Urology
Uemura Hirotsugu Japan Urology
Ürün Yüksel Turkey Medical Oncology
Vale Claire United Kingdom Clinical Trials and Statistics
van Oort Inge The Netherlands Urology
Vapiwala Neha United States Radiation Oncology
Villanti Paul Australia Movember representative
Walz Jochen France Urology
Yamoah Kosj United States Radiation Oncology
Ye Dingwei China Urology
Yu Evan United States Medical Oncology
Zapatero Almudena Spain Radiation Oncology
Zilli Thomas Switzerland Radiation Oncology

   

Members of the Scientific Committee

Bossi Alberto France Radiation Oncology
Davis Ian Australia Medical Oncology
de Bono Johann United Kingdom Medical Oncology
Fizazi Karim France Medical Oncology
Gillessen Silke Switzerland Medical Oncology
James Nicholas D. United Kingdom Clinical Oncology
Mottet Nicolas France Urology
Omlin Aurelius Switzerland Medical Oncology
Shore Neal United States Urology
Small Eric United States Medical Oncology
Smith Matthew United States Medical Oncology
Sweeney Christopher United States Medical Oncology
Tombal Bertrand Belgium Urology